On Time, Leisure, and Health in Retirement: Implications for Public Health Services

por Hutchinson, Susan, Kleiber, Douglas
Publicado 2023

Retiring from ‘University Life’: Critical Reflections on a Retirement Lifestyle Planning Program

por Woodford, Kimberley, Hutchinson, Susan, Ausman, Christine
Publicado 2022

Leisure and Leisure Education as Resources for Rehabilitation Supports for Chronic Condition Self-Management in Rural and Remote Communities

por Hutchinson, Susan, Lauckner, Heidi, Stilwell, Christie, Meisner, Brad A.
Publicado 2022

“How can I still be me?”: Strategies to maintain a sense of self in the context of a neurological condition

por Roger, Kerstin, Wetzel, Monika, Hutchinson, Susan, Packer, Tanya, Versnel, Joan
Publicado 2014

A Framework for Estimating the Eligible Patient Population for New Migraine Acute Therapies in the United States

por Harris, Linda, L’Italien, Gilbert, O’Connell, Thomas, Hasan, Zacharia, Hutchinson, Susan, Lucas, Sylvia
Publicado 2021

Picturing Recreation: Newcomers’ Perspectives on Experiences of Recreation

por Lauckner, Heidi, Gallant, Karen, Akbari, Maryam, Tomas, Giana, nee White, Tara Pride, Hutchinson, Susan
Publicado 2022

Onset, Maintenance, and Cessation of Effect of Galcanezumab for Prevention of Migraine: A Narrative Review of Three Randomized Placebo-Controlled Trials

por Kuruppu, Dulanji K., North, James M., Kovacik, Amy J., Dong, Yan, Pearlman, Eric M., Hutchinson, Susan L.
Publicado 2021

Ubrogepant for the Acute Treatment of Migraine: Pooled Efficacy, Safety, and Tolerability From the ACHIEVE I and ACHIEVE II Phase 3 Randomized Trials

por Hutchinson, Susan, Dodick, David W., Treppendahl, Christina, Bennett, Nathan L., Yu, Sung Yun, Guo, Hua, Trugman, Joel M.
Publicado 2021

Discontinuation of Acute Prescription Medication for Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study

por Lipton, Richard B., Hutchinson, Susan, Ailani, Jessica, Reed, Michael L., Fanning, Kristina M., Manack Adams, Aubrey, Buse, Dawn C.
Publicado 2019

Efficacy of ubrogepant based on prior exposure and response to triptans: A post hoc analysis

por Blumenfeld, Andrew M., Goadsby, Peter J., Dodick, David W., Hutchinson, Susan, Liu, Chengcheng, Finnegan, Michelle, Trugman, Joel M., Szegedi, Armin
Publicado 2021

Once‐daily oral atogepant for the long‐term preventive treatment of migraine: Findings from a multicenter, randomized, open‐label, phase 3 trial

por Ashina, Messoud, Tepper, Stewart J., Reuter, Uwe, Blumenfeld, Andrew M., Hutchinson, Susan, Xia, Jing, Miceli, Rosa, Severt, Lawrence, Finnegan, Michelle, Trugman, Joel M.
Publicado 2023

Real-world effectiveness, satisfaction, and optimization of ubrogepant for the acute treatment of migraine in combination with onabotulinumtoxinA: results from the COURAGE Study

por Manack Adams, Aubrey, Hutchinson, Susan, Engstrom, Ella, Ayasse, Nicolai D., Serrano, Daniel, Davis, Linda, Sommer, Katherine, Contreras-De Lama, Janette, Lipton, Richard B.
Publicado 2023

Long‐Term Safety Evaluation of Ubrogepant for the Acute Treatment of Migraine: Phase 3, Randomized, 52‐Week Extension Trial

por Ailani, Jessica, Lipton, Richard B., Hutchinson, Susan, Knievel, Kerry, Lu, Kaifeng, Butler, Matthew, Yu, Sung Yun, Finnegan, Michelle, Severt, Lawrence, Trugman, Joel M.
Publicado 2020

The everyday experience of living with and managing a neurological condition (the LINC study): study design

por Versnel, Joan, Packer, Tanya, Weeks, Lori E, Brown, Jocelyn, Godwin, Marshall, Hutchinson, Susan, Kephart, George, MacKenzie, Diane, Roger, Kerstin, Stadnyk, Robin, Villeneuve, Michelle, Warner, Grace
Publicado 2013